MelliCell Header.jpg

Where diabetes meets the cure

MelliCell develops therapeutics for diabetes and obesity using a proprietary in vitro model of weight gain in human fat cells. The products that we develop are distinct from competing therapies (e.g. GLP-1 analogs, SGLT2 inhibitors, anorexiants, intestinal lipase inhibitors, insulin secretagogues) by focusing on adipocyte-intrinsic mechanisms of action enabled by our core technology.

Curious to find out more?

Why MelliCell?

We’re a talented group of scientists & entrepreneurs, but we are also people just like you, with loved ones who suffer from disease. MelliCell helps those we care about by understanding what is happening at a cellular level and creating products to deliver better treatments and overall improved health.  

Get to know who we are.

Technology that bleeds the edge of innovation

Our groundbreaking stem-cell platform accelerates the development of drugs that promote weight loss, and ultimately a cure for diabetes. Our technology has already been recognized by leaders in the biotechnology sector and we are setting the trend for industry standards.


Get In Touch

Thanks for submitting!


About diabetes

For such a pervasive disease, diabetes is widely misunderstood. 

Here are some helpful insights about the state of this disease on a global scale.